Please use this identifier to cite or link to this item: https://dspace.iiti.ac.in/handle/123456789/3883
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSaqib, Uzmaen_US
dc.contributor.authorAlagumuthu, Manikandanen_US
dc.contributor.authorBaig, Mirza Saqiben_US
dc.date.accessioned2022-03-17T01:00:00Z-
dc.date.accessioned2022-03-17T15:30:55Z-
dc.date.available2022-03-17T01:00:00Z-
dc.date.available2022-03-17T15:30:55Z-
dc.date.issued2021-
dc.identifier.citationSaqib, U., Khan, M. A., Alagumuthu, M., Parihar, S. P., & Baig, M. S. (2021). Natural compounds as antiatherogenic agents. Cellular and Molecular Biology, 67(1) doi:10.14715/cmb/2021.67.1.27en_US
dc.identifier.issn0145-5680-
dc.identifier.otherEID(2-s2.0-85103223891)-
dc.identifier.urihttps://doi.org/10.14715/cmb/2021.67.1.27-
dc.identifier.urihttps://dspace.iiti.ac.in/handle/123456789/3883-
dc.description.abstractAtherosclerosis (AS) is a widespread pathological coronary heart disease (CHD), which, along with other cardiovascular diseases (CVDs), is the primary cause of global mortality. It is initiated by the accumulation of cholesterol-laden macrophages in the artery wall, thereby forming the foam-cells, the hallmark of AS. Increased influx of oxidized LDL and decreased efflux of free cholesterol from macrophages constitute major factors that mediate the progression of AS. Natural compounds treatment and prevention of AS being an effective approach for a long time. Currently, as interests in medicinally important natural products increased that including medicinal herbs, numerous studies on natural compounds effective forAS have been reported. In the current review, we shed light on the available plant-based natural compounds as AS modulators with underlying mechanisms that may lead to potential therapeutic implications. Copyright: © 2021 by the C.M.B. Association. All rights reserved.en_US
dc.language.isoenen_US
dc.publisherCellular and Molecular Biology Associationen_US
dc.sourceCellular and Molecular Biologyen_US
dc.subject9 cis beta caroteneen_US
dc.subjectalpha tocopherolen_US
dc.subjectampelopsinen_US
dc.subjectandrographolideen_US
dc.subjectAnnurca polyphenolic extracten_US
dc.subjectatractylenolide derivativeen_US
dc.subjectavenanthramide derivativeen_US
dc.subjectberberineen_US
dc.subjectbetulic aciden_US
dc.subjectcardiovascular agenten_US
dc.subjectchlorogenic aciden_US
dc.subjectchrysinen_US
dc.subjectcurcuma oilen_US
dc.subjectcurcuminen_US
dc.subjectdansameumen_US
dc.subjectdihydromyricetinen_US
dc.subjectdiosgeninen_US
dc.subjectellagic aciden_US
dc.subjectepigallocatechin gallateen_US
dc.subjectgarlic extracten_US
dc.subjectluteolinen_US
dc.subjectmycoepoxydieneen_US
dc.subjectnatural producten_US
dc.subjectphenylpropanoid glucosideen_US
dc.subjectplant extracten_US
dc.subjectprotocatechuic aciden_US
dc.subjectpuerarinen_US
dc.subjectquercetin 3 glucuronideen_US
dc.subjectresveratrolen_US
dc.subjectsalidrosideen_US
dc.subjectsalvianolic acid Ben_US
dc.subjectspiromastixone derivativeen_US
dc.subjecttetramethylpyrazineen_US
dc.subjectthymoquinoneen_US
dc.subjecttoddalolactoneen_US
dc.subjectubidecarenoneen_US
dc.subjectunclassified drugen_US
dc.subjectvitamin Den_US
dc.subjectantiatherogenic activityen_US
dc.subjectatherosclerosisen_US
dc.subjectdrug activityen_US
dc.subjecthumanen_US
dc.subjectnonhumanen_US
dc.subjectPiper (plant)en_US
dc.subjectReviewen_US
dc.titleNatural compounds as antiatherogenic agentsen_US
dc.typeReviewen_US
dc.rights.licenseAll Open Access, Bronze-
Appears in Collections:Department of Biosciences and Biomedical Engineering

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetric Badge: